Advertisement

Aging Clinical and Experimental Research

, Volume 31, Issue 1, pp 5–14 | Cite as

Sarcopenia and hospital-related outcomes in the old people: a systematic review and meta-analysis

  • Yunli Zhao
  • Yunxia Zhang
  • Qiukui Hao
  • Meiling Ge
  • Birong DongEmail author
Review

Abstract

Aim

This systematic review was conducted to explore the associations between sarcopenia, hospitalization and length of stay in the old people.

Methods

Pubmed, Embase, Medline and Cochrane Central Register of Controlled Trails from January 2009 to October 2017 were searched in this review. We included prospective studies, which had the clear definition of sarcopenia and reported the hospitalization or length of stay as one of outcomes. Adjusted Odd ratios (aORs), hazard ratios (aHRs) or relative risks (aRRs) extracted from the studies were combined to synthesize pooled effect measures. Heterogeneity, and methodological quality were assessed using I² statistic and Newcastle–Ottawa scale, respectively.

Results

Nine studies were included in this review. Of these, 8 studies with 4174 individuals reported results for hospitalization, 3 studies involving 6276 old people in the community reported results for length of stay. Sarcopenia was significantly associated with future hospitalization (RR 1.40, 95% CI 1.04–1.89, p = 0.029; data from 8 studies). A subgroup analysis showed the associations between sarcopenia and readmission in hospitalized old patients that were statistically significant (RR 1.75, 95% CI 1.01–3.03, p = 0.044; data from 8 studies). However, this association were not found in the community-dwelling older subjects (RR 1.08, 95% CI 0.74–1.57, p = 0.688; data from 8 studies), uncertain in nursing home residents. The association of sarcopenia and length of stay was not statistically significant (OR 1.21, 95% CI 0.90–1.63, p = 0.20; data from 8 studies) in community-dwelling residents.

Conclusions

This systematic review demonstrates that sarcopenia is a significant predictor of readmission in old inpatients, but not associated with hospitalization or length of stay in community-dwelling old adults.

Keywords

Aged Hospitalization Length of stay Sarcopenia. 

Notes

Author contributions

YL formulated the research question, designed the study and screened the articles, collected the data, and drafted the manuscript. YX designed the study and screened the articles. QK collected the data. ML analyzed the data.BD assisted with formulating the research question and supervising the quality of the paper.

Funding

The authors declare that they have received no funding for the study

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest

Ethical approval

For this type of study, formal consent is not required.

Human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

This type of study is based on aggregated data of already published studies. Informed consent can not be obtained from patients.

Supplementary material

40520_2018_931_MOESM1_ESM.pdf (35 kb)
Supplementary material 1 (PDF 35 KB)
40520_2018_931_MOESM2_ESM.tif (4.6 mb)
Supplementary material 2 (TIF 4672 KB)
40520_2018_931_MOESM3_ESM.tif (4.6 mb)
Supplementary material 3 (TIF 4671 KB)
40520_2018_931_MOESM4_ESM.doc (55 kb)
Supplementary material 4 (DOC 55 KB)

References

  1. 1.
    Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP (2010) Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 13:1–7.  https://doi.org/10.1097/MCO.0b013e328333c1c1 CrossRefGoogle Scholar
  2. 2.
    Cao L, Morley JE (2016) Sarcopenia is recognized as an independent condition by an international classification of disease, tenth revision, Clinical MODIFICATION (ICD-10-CM) Code. J Am Med Dir Assoc 17:675–677.  https://doi.org/10.1016/j.jamda.2016.06.001 CrossRefGoogle Scholar
  3. 3.
    Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763CrossRefGoogle Scholar
  4. 4.
    Newman AB, Kupelian V, Visser M et al (2003) Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 51:1602–1609CrossRefGoogle Scholar
  5. 5.
    Fielding RA, Vellas B, Evans WJ et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12:249–256.  https://doi.org/10.1016/j.jamda.2011.01.003 CrossRefGoogle Scholar
  6. 6.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423.  https://doi.org/10.1093/ageing/afq034 CrossRefGoogle Scholar
  7. 7.
    Studenski SA, Peters KW, Alley DE et al (2014) The FNIH Sarcopenia Project: rationale, study description, conference recommendations and final estimates. J Gerontol A Biol Sci Med Sci 69:547–558.  https://doi.org/10.1093/gerona/glu010 CrossRefGoogle Scholar
  8. 8.
    Chen LK, Liu LK, Woo J, Assantachai P et al (2014) Sarcopenia in Asia: consensus report of the asian working group for sarcopenia. J Am Med Dir Assoc 15:95–101.  https://doi.org/10.1016/j.jamda.2013.11.025 CrossRefGoogle Scholar
  9. 9.
    Yoshimura N, Oka H, Muraki S et al (2011) Reference values for hand grip strength, muscle mass, walking time, and one-leg standing time as indices for locomotive syndrome and associated disability: the second survey of the ROAD study. J Orthop Sci 16:768–777.  https://doi.org/10.1007/s00776-011-0160-1 CrossRefGoogle Scholar
  10. 10.
    Cruz-Jentoft AJ, Landi F, Schneider SM et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Initiative(EWGSOP and IWGS). Age Ageing 43:748–759.  https://doi.org/10.1093/ageing/afu115 CrossRefGoogle Scholar
  11. 11.
    Levant S, Chari K, DeFrances CJ (2015) Hospitalizations for patients aged 85 and over in the United States, 2000–2010. NCHS Data Brief 182:1–8Google Scholar
  12. 12.
    Gariballa S, Alessa A (2013) Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clin Nutr 32:772–776.  https://doi.org/10.1016/j.clnu.2013.01.010 CrossRefGoogle Scholar
  13. 13.
    Woo J, Leung J, Morley JE (2015) Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc 16:247–252.  https://doi.org/10.1016/j.jamda.2014.11.013 CrossRefGoogle Scholar
  14. 14.
    Bianchi L, Ferrucci L, Cherubini A et al (2016) The predictive value of the EWGSOP definition of sarcopenia: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 71:259–264.  https://doi.org/10.1093/gerona/glv129 CrossRefGoogle Scholar
  15. 15.
    Wang Rong,HuYixin,Fan, Li et al (2016) Effect of sarcopenia on the rate of rehospitalization in elderly male patients. Chin J Health Care Med 02:106–109Google Scholar
  16. 16.
    Henwood T, Hassan B, Swinton P, Senior H, Keogh J (2017) Consequences of sarcopenia among nursing home residents at long-term follow-up. Geriatr Nurs 38:406–411.  https://doi.org/10.1016/j.gerinurse CrossRefGoogle Scholar
  17. 17.
    Yang M, Hu X, Wang H, Zhang L, Hao Q, Dong B (2017) Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study. J Cachexia Sarcopenia Muscle 8:251–258.  https://doi.org/10.1002/jcsm.12163 CrossRefGoogle Scholar
  18. 18.
    Cawthon PM, Lui LY, McCulloch CE et al (2017) Sarcopenia and health care utilization in older women. J Gerontol A Biol Sci Med Sci 72:95–101.  https://doi.org/10.1093/gerona/glw118 CrossRefGoogle Scholar
  19. 19.
    Cawthon PM, Lui LY, Taylor BC et al (2017) Clinical definitions of sarcopenia and risk of hospitalization in community-dwelling older men: the osteoporotic fractures in men study. J Gerontol A Biol Sci Med Sci 72:1383–1389.  https://doi.org/10.1093/gerona/glw327 CrossRefGoogle Scholar
  20. 20.
    Beaudart C, Zaaria M, Pasleau F et al (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One 12:e0169548.  https://doi.org/10.1371/journal.pone.0169548 CrossRefGoogle Scholar
  21. 21.
    Wells GA, Shea B, O’Connell D et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 18 Dec 2017
  22. 22.
    Zhang J, Yu KF (1998) What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280:1690–1691CrossRefGoogle Scholar
  23. 23.
    Pérez-Zepeda MU, Sgaravatti A, Dent E (2017) Sarcopenia and post-hospital outcomes in older adults: a longitudinal study. Arch Gerontol Geriatr 69:105–109.  https://doi.org/10.1016/j.archger.2016.10.013 CrossRefGoogle Scholar
  24. 24.
    Henwood T, Hassan B, Swinton P, Senior H, Keogh J (2017) Consequences of sarcopenia among nursing home residents at long-term follow-up. Geriatr Nurs Sep–Oct 38(5):406–411.  https://doi.org/10.1016/j.gerinurse.2017.02.003 CrossRefGoogle Scholar
  25. 25.
    Huang DD, Zhou CJ, Wang SL et al (2017) Impact of different sarcopenia stages on the postoperative outcomes after radical gastrectomy for gastric cancer. Surgery 161:680–693.  https://doi.org/10.1016/j.surg.2016.08.030 CrossRefGoogle Scholar
  26. 26.
    Hsu YH, Liang CK, Chou MY et al (2014) Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan: a cross-sectional study. Geriatr Gerontol Int 14 (Suppl 1):102–108.  https://doi.org/10.1111/ggi.12221 CrossRefGoogle Scholar
  27. 27.
    Springer J, Anker SD (2016) Publication trends in cachexia and sarcopenia in elderly heart failure patients. Wien Klin Wochenschr 128:446–454.  https://doi.org/10.1007/s00508-016-1126-2 CrossRefGoogle Scholar
  28. 28.
    Bone AE, Hepgul N, Kon S, Maddocks M (2017) Sarcopenia and frailty in chronic respiratory disease. Chron Respir Dis 14:85–99.  https://doi.org/10.1177/1479972316679664 CrossRefGoogle Scholar
  29. 29.
    Sinclair M, Gow PJ, Grossmann M, Angus PW (2016) Review article: sarcopenia in cirrhosis–aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther 43:765–777.  https://doi.org/10.1111/apt.13549 CrossRefGoogle Scholar
  30. 30.
    Jang HC (2016) Sarcopenia, frailty, and diabetes in older adults. Diabetes Metab J 40:182–189.  https://doi.org/10.4093/dmj.2016.40.3.182 CrossRefGoogle Scholar
  31. 31.
    Collins J, Noble S, Chester J, Coles B, Byrne A (2014) The assessment and impact of sarcopenia in lung cancer: a systematic literature review. BMJ Open 4:e003697.  https://doi.org/10.1136/bmjopen-2013-003697 CrossRefGoogle Scholar
  32. 32.
    Martone AM, Bianchi L, Abete P et al (2017) The incidence of sarcopenia among hospitalized older patients: results from the Glisten study. J Cachexia Sarcopenia Muscle 8:907–914.  https://doi.org/10.1002/jcsm.12224 CrossRefGoogle Scholar
  33. 33.
    Ali S, Garcia JM (2014) Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options—a mini-review. Gerontology 60:294–305.  https://doi.org/10.1159/000356760 CrossRefGoogle Scholar
  34. 34.
    Liu CJ, Latham NK (2009) Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev (3):CD002759.  https://doi.org/10.1002/14651858
  35. 35.
    Calvani R, Miccheli A, Landi F et al (2013) Current nutritional recommendations and novel dietary strategies to manage sarcopenia. J Frailty Aging 2:38–53Google Scholar
  36. 36.
    Morley JE, Argiles JM, Evans WJ et al (2010) Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 11:391–396.  https://doi.org/10.1016/j.jamda CrossRefGoogle Scholar
  37. 37.
    Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR et al (2008) Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 299:39–52.  https://doi.org/10.1001/jama.2007.51 Google Scholar
  38. 38.
    Cappola AR (2013) Testosterone therapy and risk of cardiovascular disease in men. JAMA 310:1805–1806.  https://doi.org/10.1001/jama.2013.280387 CrossRefGoogle Scholar
  39. 39.
    Morley JE, Kaiser FE, Perry HM et al (1997) Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 46:410–413CrossRefGoogle Scholar
  40. 40.
    Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–635.  https://doi.org/10.1016/S1470-2045(08)70153-0 CrossRefGoogle Scholar
  41. 41.
    Shen W, Punyanitya M, Wang Z et al (2004) Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol (1985) 97:2333–2338.  https://doi.org/10.1152/japplphysiol.00744.2004 CrossRefGoogle Scholar
  42. 42.
    Peterson SJ, Braunschweig CA (2016) Prevalence of sarcopenia and associated outcomes in the clinical setting. Nutr Clin Pract 31:40–48.  https://doi.org/10.1177/0884533615622537 CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Yunli Zhao
    • 1
    • 2
  • Yunxia Zhang
    • 2
    • 3
  • Qiukui Hao
    • 1
    • 2
  • Meiling Ge
    • 1
    • 2
  • Birong Dong
    • 1
    • 2
    Email author
  1. 1.The Center of Gerontology and Geriatrics, West China HospitalSichuan UniversityChengduChina
  2. 2.National Clinical Research Center for GeriatricsChengduChina
  3. 3.The Center of Coordination and Innovation for Aging Care and Health Promotion of SichuanChengdu Medical SchoolChengduChina

Personalised recommendations